IS6429A - Indólafleiður sem MCP-1 viðtakamótlyf - Google Patents

Indólafleiður sem MCP-1 viðtakamótlyf

Info

Publication number
IS6429A
IS6429A IS6429A IS6429A IS6429A IS 6429 A IS6429 A IS 6429A IS 6429 A IS6429 A IS 6429A IS 6429 A IS6429 A IS 6429A IS 6429 A IS6429 A IS 6429A
Authority
IS
Iceland
Prior art keywords
mcp
receptor antagonists
indole derivatives
indole
derivatives
Prior art date
Application number
IS6429A
Other languages
English (en)
Inventor
Wellington Faull Alan
Grant Kettle Jason
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6429A publication Critical patent/IS6429A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IS6429A 2000-01-13 2002-06-19 Indólafleiður sem MCP-1 viðtakamótlyf IS6429A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000626.2A GB0000626D0 (en) 2000-01-13 2000-01-13 Chemical compounds
PCT/GB2001/000069 WO2001051466A1 (en) 2000-01-13 2001-01-11 Indole derivatives as mcp-1 receptor antagonists

Publications (1)

Publication Number Publication Date
IS6429A true IS6429A (is) 2002-06-19

Family

ID=9883551

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6429A IS6429A (is) 2000-01-13 2002-06-19 Indólafleiður sem MCP-1 viðtakamótlyf

Country Status (25)

Country Link
US (1) US20030144339A1 (is)
EP (1) EP1252142A1 (is)
JP (1) JP2003519683A (is)
KR (1) KR20020064375A (is)
CN (1) CN1395565A (is)
AR (1) AR026839A1 (is)
AU (1) AU780992B2 (is)
BG (1) BG106894A (is)
BR (1) BR0107404A (is)
CA (1) CA2393592A1 (is)
CO (1) CO5271703A1 (is)
EE (1) EE200200394A (is)
GB (1) GB0000626D0 (is)
HK (1) HK1049486A1 (is)
HU (1) HUP0300694A3 (is)
IL (1) IL150272A0 (is)
IS (1) IS6429A (is)
MX (1) MXPA02006611A (is)
NO (1) NO20023380L (is)
NZ (1) NZ519312A (is)
PL (1) PL356031A1 (is)
RU (1) RU2002121636A (is)
SK (1) SK10072002A3 (is)
WO (1) WO2001051466A1 (is)
ZA (1) ZA200204354B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
WO2004069809A1 (en) 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
WO2006030946A1 (ja) * 2004-09-13 2006-03-23 Kureha Corporation 熱発泡性マイクロスフェアー、その製造方法、その使用、それを含む組成物、及び物品
EP1960401B1 (en) 2005-12-09 2009-11-11 F.Hoffmann-La Roche Ag Tricyclic amide derivatives useful for treating obesity
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
US7507736B2 (en) 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
DK2134685T3 (en) * 2007-04-16 2015-12-07 Abbvie Inc 7-unsubstituted indole derivatives as MCL-1 inhibitors
WO2023224981A1 (en) * 2022-05-17 2023-11-23 Inipharm, Inc. Hsd17b13 inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529724A (en) * 1983-10-11 1985-07-16 Mcneilab, Inc. 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5273980A (en) * 1991-09-30 1993-12-28 Merck Frosst Canada Inc. Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US5686481A (en) * 1993-12-21 1997-11-11 Smithkline Beecham Corporation Endothelin receptor antagonists
US5482960A (en) * 1994-11-14 1996-01-09 Warner-Lambert Company Nonpeptide endothelin antagonists
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
EP1021181A4 (en) * 1996-03-28 2002-06-26 Smithkline Beecham Corp INDOLCARBOXYLIC ACIDS AS CHEMOKIN INHIBITORS
AU4054197A (en) * 1996-08-14 1998-03-06 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803226D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9902461D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2393592A1 (en) 2001-07-19
RU2002121636A (ru) 2004-01-10
EP1252142A1 (en) 2002-10-30
CN1395565A (zh) 2003-02-05
HK1049486A1 (zh) 2003-05-16
WO2001051466A1 (en) 2001-07-19
PL356031A1 (en) 2004-06-14
AU2532401A (en) 2001-07-24
EE200200394A (et) 2003-12-15
KR20020064375A (ko) 2002-08-07
HUP0300694A2 (hu) 2003-07-28
ZA200204354B (en) 2003-09-01
GB0000626D0 (en) 2000-03-01
IL150272A0 (en) 2002-12-01
NO20023380L (no) 2002-09-03
CO5271703A1 (es) 2003-04-30
JP2003519683A (ja) 2003-06-24
BR0107404A (pt) 2002-10-08
US20030144339A1 (en) 2003-07-31
SK10072002A3 (sk) 2003-06-03
HUP0300694A3 (en) 2005-08-29
NO20023380D0 (no) 2002-07-12
MXPA02006611A (es) 2002-09-30
NZ519312A (en) 2004-04-30
BG106894A (bg) 2003-04-30
AU780992B2 (en) 2005-04-28
AR026839A1 (es) 2003-02-26

Similar Documents

Publication Publication Date Title
IS5980A (is) Indól afleiður og notkun þeirra sem MCP-1 mótlyf
ATE400558T1 (de) Metabotropische glutamatrezeptor-antagonisten
HK1076459A1 (en) 4-Phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
PL365377A1 (en) Amide derivatives as nmda receptor antagonists
CY2010003I1 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
IS4838A (is) Indól afleiður nytsamlegar sem innanþekjuviðtaka mótlyf
IL153837A0 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
EE200200612A (et) Tsükloheksüülamiini derivaadid kui alatüübi selektiivsed NMDA-retseptori antagonistid
NO20016077D0 (no) Makrofag-oppfanger-reseptorantagonister
NO20015779L (no) Bradykinin-reseptorantagonister
IS6821A (is) Samrunnar afleiður púríns sem mótlyf A1-adenósínviðtakans
IS6429A (is) Indólafleiður sem MCP-1 viðtakamótlyf
DE60130000D1 (de) Zwitterionische tachykinin-rezeptor-antagonisten
IS8278A (is) Sýkóprópýl afleiður sem NK3 viðtaka mótlyf
ATE244716T1 (de) Neue n-triazolylmethyl-piperazinderivate als neurokininrezeptor-antagonisten
DE60134836D1 (de) Il-9 receptor-antagonisten